Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Schirrmacher

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
International Archives of Allergy and Immunology|December 1, 1995
Tumor vaccine design: concepts, mechanisms, and efficacy testingV Schirrmacher
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Biotherapy of cancer. Perspectives of immunotherapy and gene therapyV Schirrmacher
Behring Institute Mitteilungen|May 1, 1984
Cancer metastasis and the use of animal model systemsV Schirrmacher
Invasion & Metastasis|January 1, 1981
Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) miceV Schirrmacher
International Journal of Oncology|May 11, 2011
Augmentation of protective immunotherapy against metastatic esb lymphoma-cells by combining immune cell transfer with host irradiation, antigen restimulation and/or anti-tnf-alpha antibody treatmentV Schirrmacher
Zentralblatt Fur Chirurgie|August 10, 2000
[Anti-tumor vaccination]V Schirrmacher
Zeitschrift Fur Gastroenterologie. Verhandlungsband|July 1, 1989
[Cell biology principles of metastasis and strategies for immunotherapy]V Schirrmacher
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Mechanisms of metastatic spread to liverV Schirrmacher
Der Internist|February 7, 1998
[Tumor vaccines and active specific immunotherapy]V Schirrmacher
Cancer Surveys|January 1, 1992
Immunity and metastasis: in situ activation of protective T cells by virus modified cancer vaccinesV Schirrmacher
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
International Archives of Allergy and Immunology|December 1, 1995
Tumor vaccine design: concepts, mechanisms, and efficacy testingV Schirrmacher
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Biotherapy of cancer. Perspectives of immunotherapy and gene therapyV Schirrmacher
Behring Institute Mitteilungen|May 1, 1984
Cancer metastasis and the use of animal model systemsV Schirrmacher
Invasion & Metastasis|January 1, 1981
Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) miceV Schirrmacher
International Journal of Oncology|May 11, 2011
Augmentation of protective immunotherapy against metastatic esb lymphoma-cells by combining immune cell transfer with host irradiation, antigen restimulation and/or anti-tnf-alpha antibody treatmentV Schirrmacher
Zentralblatt Fur Chirurgie|August 10, 2000
[Anti-tumor vaccination]V Schirrmacher
Zeitschrift Fur Gastroenterologie. Verhandlungsband|July 1, 1989
[Cell biology principles of metastasis and strategies for immunotherapy]V Schirrmacher
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Mechanisms of metastatic spread to liverV Schirrmacher
Der Internist|February 7, 1998
[Tumor vaccines and active specific immunotherapy]V Schirrmacher
Cancer Surveys|January 1, 1992
Immunity and metastasis: in situ activation of protective T cells by virus modified cancer vaccinesV Schirrmacher
Pageof 30